Fig. 4From: Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose studyHTL0018318 mean plasma concentration after 15, 20, 25 or 35 mg for elderly subjectsBack to article page